Fennec Pharmaceuticals (FENC) Payables (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Payables of $4.6 million for Q4 2025, up 43.01% year-on-year from $3.2 million in Q4 2024, and down 20.99% on a QoQ basis from $5.9 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Payables data on file, last reported at $4.6 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 43.01% year-over-year to $4.6 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (up 43.01% YoY), and the FY2025 full-year result was $4.6 million, up 43.01% from the prior year.
- Payables for Q4 2025 stood at $4.6 million, down from $5.9 million in the prior quarter.
- Across five years, Payables topped out at $5.9 million in Q2 2025 and bottomed at $677000.0 in Q2 2021.
- The 5-year median for Payables is $3.0 million (2023), against an average of $3.2 million.
- The widest annual swing landed in 2021, when Payables slumped 75.43%; it then surged 207.59% in 2022.
- A 5-year view of Payables shows it stood at $777000.0 in 2021, then soared by 207.59% to $2.4 million in 2022, then soared by 58.08% to $3.8 million in 2023, then fell by 14.21% to $3.2 million in 2024, then surged by 43.01% to $4.6 million in 2025.
- The last three Payables figures came in at $4.6 million (Q4 2025), $5.9 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 2.39 Mn |
| Sep 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 777,000.00 |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 677,000.00 |
| Mar 31, 2021 | 2.51 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 2.68 Mn |
| Jun 30, 2020 | 2.76 Mn |
| Mar 31, 2020 | 1.68 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Sep 30, 2019 | 788,000.00 |
| Jun 30, 2019 | 1.23 Mn |
| Mar 31, 2019 | 1.30 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.87 Mn |
| Jun 30, 2018 | 709,000.00 |
| Mar 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | 855,000.00 |
| Sep 30, 2017 | 492,000.00 |
| Jun 30, 2017 | 296,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 244,000.00 |
| Sep 30, 2016 | 235,000.00 |
| Jun 30, 2016 | 345,000.00 |
| Mar 31, 2016 | 225,000.00 |
| Dec 31, 2015 | 297,000.00 |
| Sep 30, 2015 | 252,000.00 |
| Jun 30, 2015 | 401,000.00 |
| Mar 31, 2015 | 384,000.00 |
| Dec 31, 2014 | 308,000.00 |
| Sep 30, 2014 | 364,000.00 |
| Jun 30, 2014 | 335,000.00 |
| Mar 31, 2014 | 154,000.00 |
| Dec 31, 2013 | 212,000.00 |
| Sep 30, 2013 | 315,000.00 |
| Jun 30, 2013 | 716,000.00 |
| Mar 31, 2013 | 698,000.00 |
| Dec 31, 2012 | 259,000.00 |
| Sep 30, 2012 | 315,000.00 |
| Jun 30, 2012 | 276,000.00 |
| Mar 31, 2012 | 374,000.00 |
| Dec 31, 2011 | 342,000.00 |
| Sep 30, 2011 | 414,000.00 |
| Jun 30, 2011 | 239,000.00 |
| Dec 31, 2010 | 272,000.00 |